These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20547745)

  • 1. Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract.
    Sturdevant GL; Kari L; Gardner DJ; Olivares-Zavaleta N; Randall LB; Whitmire WM; Carlson JH; Goheen MM; Selleck EM; Martens C; Caldwell HD
    Infect Immun; 2010 Sep; 78(9):3660-8. PubMed ID: 20547745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectivity of urogenital Chlamydia trachomatis plasmid-deficient, CT135-null, and double-deficient strains in female mice.
    Sturdevant GL; Zhou B; Carlson JH; Whitmire WM; Song L; Caldwell HD
    Pathog Dis; 2014 Jun; 71(1):90-2. PubMed ID: 24376189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia trachomatis virulence factor CT135 is stable in vivo but highly polymorphic in vitro.
    Bonner C; Caldwell HD; Carlson JH; Graham MR; Kari L; Sturdevant GL; Tyler S; Zetner A; McClarty G
    Pathog Dis; 2015 Aug; 73(6):ftv043. PubMed ID: 26109550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    BMC Infect Dis; 2005 Nov; 5():105. PubMed ID: 16293190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid CDS5 influences infectivity and virulence in a mouse model of Chlamydia trachomatis urogenital infection.
    Ramsey KH; Schripsema JH; Smith BJ; Wang Y; Jham BC; O'Hagan KP; Thomson NR; Murthy AK; Skilton RJ; Chu P; Clarke IN
    Infect Immun; 2014 Aug; 82(8):3341-9. PubMed ID: 24866804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.
    Darville T; Andrews CW; Laffoon KK; Shymasani W; Kishen LR; Rank RG
    Infect Immun; 1997 Aug; 65(8):3065-73. PubMed ID: 9234755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chlamydia trachomatis Plasmid and CT135 Virulence Factors Are Not Essential for Genital Tract Infection or Pathology in Female Pig-Tailed Macaques.
    Patton DL; Sweeney YC; Baldessari AE; Cles L; Kari L; Sturdevant GL; Yang C; Caldwell HD
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29463617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model.
    Sigar IM; Schripsema JH; Wang Y; Clarke IN; Cutcliffe LT; Seth-Smith HM; Thomson NR; Bjartling C; Unemo M; Persson K; Ramsey KH
    Pathog Dis; 2014 Feb; 70(1):61-9. PubMed ID: 24022847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
    Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
    Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: host factors as major determinants of C trachomatis mediated pathogenesis.
    Lyons JM; Ito JI; Morré SA
    J Clin Pathol; 2004 Jun; 57(6):657-9. PubMed ID: 15166277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis Plasmid Gene Protein 3 Is Essential for the Establishment of Persistent Infection and Associated Immunopathology.
    Yang C; Kari L; Lei L; Carlson JH; Ma L; Couch CE; Whitmire WM; Bock K; Moore I; Bonner C; McClarty G; Caldwell HD
    mBio; 2020 Aug; 11(4):. PubMed ID: 32817110
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.
    Borges V; Pinheiro M; Antelo M; Sampaio DA; Vieira L; Ferreira R; Nunes A; Almeida F; Mota LJ; Borrego MJ; Gomes JP
    PLoS One; 2015; 10(7):e0133420. PubMed ID: 26207372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model.
    Carmichael JR; Tifrea D; Pal S; de la Maza LM
    Microbes Infect; 2013 Mar; 15(3):219-29. PubMed ID: 23287699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Persistence of Chlamydia trachomatis Sexually Transmitted Strains Involves Novel Mutations in the Functional αββα Tetramer of the Tryptophan Synthase Operon.
    Somboonna N; Ziklo N; Ferrin TE; Hyuk Suh J; Dean D
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational Analysis of the Chlamydia muridarum Plasticity Zone.
    Rajaram K; Giebel AM; Toh E; Hu S; Newman JH; Morrison SG; Kari L; Morrison RP; Nelson DE
    Infect Immun; 2015 Jul; 83(7):2870-81. PubMed ID: 25939505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.
    Ito JI; Lyons JM; Airo-Brown LP
    Infect Immun; 1990 Jun; 58(6):2021-3. PubMed ID: 2341189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.
    Vicetti Miguel RD; Quispe Calla NE; Pavelko SD; Cherpes TL
    PLoS One; 2016; 11(9):e0162445. PubMed ID: 27606424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs?
    Darville T; Andrews CW; Rank RG
    Infect Immun; 2000 Sep; 68(9):5299-305. PubMed ID: 10948158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydial Plasmid-Dependent Pathogenicity.
    Zhong G
    Trends Microbiol; 2017 Feb; 25(2):141-152. PubMed ID: 27712952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.